Hikari Power’s Stemline Therapeutics, Inc. STML Stock Holding History

Hikari Power’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,000	Closed	-$97K	–	81
2020 Q1	$97K	Buy	+20,000	New	+$130K	0.01%	79
2019 Q2	–	Sell	-15,136	Closed	-$194K	–	149
2019 Q1	$194K	Hold	15,136	–	–	0.02%	117
2018 Q4	$144K	Buy	+15,136	New	+$196K	0.02%	121

Hikari Power's STML Position: Q2 2020 in Review

Hikari Power sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 20,000 shares — an estimated $97K sold.

Hikari Power first reported a position in STML in Q4 2018 and held it in 3 quarters. The position peaked at $194K in Q1 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Hikari Power reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Hikari Power sold 20,000 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $97K.
Hikari Power first reported a position in Stemline Therapeutics, Inc. in Q4 2018 and held it in 3 quarters.
Hikari Power's Stemline Therapeutics, Inc. position peaked at $194K in Q1 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Hikari Power's 13F filing for Q2 2020, filed 13 Aug 2020.